Xin Yue Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xin Yue Guo has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Aldo Saavedra
The University of Sydney Sydney New South Wales Australia
1 shared publication Alice Flanagan
Prince of Wales Hospital, Randwick, Australia
1 shared publicationConstantine Zois
Department of Respiratory and Sleep Medicine Prince of Wales Hospital Randwick New South Wales Australia
1 shared publicationEmily MacKinlay
Prince of Wales Hospital, Randwick, Australia
1 shared publication- Fang Liu
School of Management, Guangzhou University, Guangzhou, China
1 shared publication - Gordon D. McDonald
Quantum Sensors and Atomlaser Lab, Department of Quantum Science, Australian National University, Canberra 0200, Australia
1 shared publication
Latest Publications
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA4856
Bridging acute to community care: Australian implementation of a COPD discharge care bundle and its effect on readmissions
Background: Chronic obstructive pulmonary disease (COPD) causes substantial health and economic burdens in Australia and globally, with high hospitalization and preventable bed days. Discharge care bundles may reduce readmissions, but evidence is inconsistent. The Australian COPD Clinical Care Standard (2024) highlights improved inpatient care and community follow-ups to prevent exacerbation, yet no standardized discharge bundle exists nationally. Aim: To evaluate the effectiveness and clinical applicability of a multidisciplinary discharge care bundle in reducing hospital readmissions after acute COPD exacerbations. Methods: A single-centre, pre–post intervention study included 255 patients admitted with acute exacerbations at a tertiary Sydney hospital. Primary outcomes were 28- and 60-day readmission rates. Adherence to bundle components (Table 1) was assessed. Outcomes were analyzed using chi-squared tests and descriptive statistics. erj;68/suppl_70/PA4856/TB1 T1 TB1 Table 1. COPD Discharge Care Bundle Assessment of smoking status and willingness to quit Inhaler technique assessment COPD action plan Refer to community follow up Results: 138 pre- and 117 post-intervention patients were included. Implementation improved documentation of smoking status, COPD action plans, and community follow-up. 28-day readmissions remained similar (20.8% vs 23.3%; OR 1.41, P=0.12), while 60-day readmissions decreased (31.2% vs 15.8%; OR 1.49, P=0.27). Full bundle completion was low, and higher readmissions among patients receiving the complete bundle likely reflected small sample size. Discussion: Although full delivery of the bundle was limited, this first Australian application of a structured COPD discharge bundle highlights opportunities to bridge the gap in care transitions and inform future interventions.
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA4856
Bridging acute to community care: Australian implementation of a COPD discharge care bundle and its effect on readmissions
Background: Chronic obstructive pulmonary disease (COPD) causes substantial health and economic burdens in Australia and globally, with high hospitalization and preventable bed days. Discharge care bundles may reduce readmissions, but evidence is inconsistent. The Australian COPD Clinical Care Standard (2024) highlights improved inpatient care and community follow-ups to prevent exacerbation, yet no standardized discharge bundle exists nationally. Aim: To evaluate the effectiveness and clinical applicability of a multidisciplinary discharge care bundle in reducing hospital readmissions after acute COPD exacerbations. Methods: A single-centre, pre–post intervention study included 255 patients admitted with acute exacerbations at a tertiary Sydney hospital. Primary outcomes were 28- and 60-day readmission rates. Adherence to bundle components (Table 1) was assessed. Outcomes were analyzed using chi-squared tests and descriptive statistics. erj;68/suppl_70/PA4856/TB1 T1 TB1 Table 1. COPD Discharge Care Bundle Assessment of smoking status and willingness to quit Inhaler technique assessment COPD action plan Refer to community follow up Results: 138 pre- and 117 post-intervention patients were included. Implementation improved documentation of smoking status, COPD action plans, and community follow-up. 28-day readmissions remained similar (20.8% vs 23.3%; OR 1.41, P=0.12), while 60-day readmissions decreased (31.2% vs 15.8%; OR 1.49, P=0.27). Full bundle completion was low, and higher readmissions among patients receiving the complete bundle likely reflected small sample size. Discussion: Although full delivery of the bundle was limited, this first Australian application of a structured COPD discharge bundle highlights opportunities to bridge the gap in care transitions and inform future interventions.
- Open Access
- 1 May 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (5) , e70584
Successful Sequential and Additive Drug Challenge With Rapid Oral Desensitization in Rifampicin‐Induced Fever
Adverse drug reactions to first‐line antituberculosis (anti‐TB) therapy are common and may necessitate treatment interruption. While drug desensitization is increasingly used for delayed hypersensitivity, evidence supporting outpatient rapid oral desensitization in mild delayed reactions such as drug‐induced fever is limited. We report a 63‐year‐old man with active pulmonary tuberculosis who developed drug‐induced fever after commencing standard anti‐TB therapy. Sequential and additive drug challenge identified rifampicin as the offending agent. The patient subsequently underwent successful rapid oral rifampicin desensitization in an outpatient setting, enabling completion of 6 months of therapy without recurrence of adverse effects. This case demonstrates the feasibility of outpatient rapid oral desensitization for mild delayed hypersensitivity reactions, including drug‐induced fever. Such an approach may reduce treatment interruption and hospitalisation, particularly in settings where standardised outpatient desensitization protocols are lacking. Further studies are needed to define optimal strategies for managing mild delayed hypersensitivity reactions to anti‐TB medications.
- 1 May 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (5) , e70584
Open AccessSuccessful Sequential and Additive Drug Challenge With Rapid Oral Desensitization in Rifampicin‐Induced Fever
Adverse drug reactions to first‐line antituberculosis (anti‐TB) therapy are common and may necessitate treatment interruption. While drug desensitization is increasingly used for delayed hypersensitivity, evidence supporting outpatient rapid oral desensitization in mild delayed reactions such as drug‐induced fever is limited. We report a 63‐year‐old man with active pulmonary tuberculosis who developed drug‐induced fever after commencing standard anti‐TB therapy. Sequential and additive drug challenge identified rifampicin as the offending agent. The patient subsequently underwent successful rapid oral rifampicin desensitization in an outpatient setting, enabling completion of 6 months of therapy without recurrence of adverse effects. This case demonstrates the feasibility of outpatient rapid oral desensitization for mild delayed hypersensitivity reactions, including drug‐induced fever. Such an approach may reduce treatment interruption and hospitalisation, particularly in settings where standardised outpatient desensitization protocols are lacking. Further studies are needed to define optimal strategies for managing mild delayed hypersensitivity reactions to anti‐TB medications.
- Open Access
- 1 January 2022
- Published by China Science Publishing & Media Ltd. in Acta Psychologica Sinica
- Vol. 54 (1) , 25-39
Relationship between depression and cognitive reappraisal in 8-12 years old children: The mediating role of attention bias toward sad expression
- 1 January 2022
- Published by China Science Publishing & Media Ltd. in Acta Psychologica Sinica
- Vol. 54 (1) , 25-39
Open AccessRelationship between depression and cognitive reappraisal in 8-12 years old children: The mediating role of attention bias toward sad expression
- 22 June 2019
- Published by BMJ in Archives of Disease in Childhood
- Vol. 104 (12) , 1150-1154
Discharge against medical advice in culturally and linguistically diverse Australian children
Objectives This study quantifies the prevalence and rates of discharge against medical advice (DAMA) in culturally and linguistically diverse (CALD) children and assesses the independent association between CALD status and DAMA accounting for key demographic confounders in a large tertiary Australian hospital network. Methods Prospectively collected data between 2010 and 2018 were extracted from the hospital network electronic medical records system for admitted patients (n=192 037), outpatients (n=268 904) and between 2015 and 2018 for emergency department (ED) patients (n=158 903). CALD status was defined as ‘preferred language being not English’ and DAMA was measured as ‘discharge at own risk’ in admissions, ‘no show’ in outpatients, ‘left without being seen’ and ‘did not wait’ in ED. Data were analysed using χ² test, bivariate analysis and multivariate logistic regression. Results The prevalence of DAMA was 1.34% in admitted patients, 19.31% in outpatients and 12.64% in ED patients. Rates of DAMA were higher among CALD children compared to non-CALD children (1.75% vs 1.29% in admitted patients, 26.53% vs 17.92% in outpatients and 18.74% vs 11.61% in ED patients). CALD status was independently associated with DAMA in admitted children (OR=1.30, 95% CI 1.15 to 1.44), outpatients (OR=1.55; 95% CI 1.51 to 1.58) and ED patients (OR=1.60; 95% CI 1.53 to 1.66). Conclusion Being from a CALD background places children at increased risks to DAMA. Implementing appropriate health service responses may ensure equitable access and quality care for children from CALD backgrounds to reduce the rates of DAMA and its associated ramifications.
- 22 June 2019
- Published by BMJ in Archives of Disease in Childhood
- Vol. 104 (12) , 1150-1154
Discharge against medical advice in culturally and linguistically diverse Australian children
Objectives This study quantifies the prevalence and rates of discharge against medical advice (DAMA) in culturally and linguistically diverse (CALD) children and assesses the independent association between CALD status and DAMA accounting for key demographic confounders in a large tertiary Australian hospital network. Methods Prospectively collected data between 2010 and 2018 were extracted from the hospital network electronic medical records system for admitted patients (n=192 037), outpatients (n=268 904) and between 2015 and 2018 for emergency department (ED) patients (n=158 903). CALD status was defined as ‘preferred language being not English’ and DAMA was measured as ‘discharge at own risk’ in admissions, ‘no show’ in outpatients, ‘left without being seen’ and ‘did not wait’ in ED. Data were analysed using χ² test, bivariate analysis and multivariate logistic regression. Results The prevalence of DAMA was 1.34% in admitted patients, 19.31% in outpatients and 12.64% in ED patients. Rates of DAMA were higher among CALD children compared to non-CALD children (1.75% vs 1.29% in admitted patients, 26.53% vs 17.92% in outpatients and 18.74% vs 11.61% in ED patients). CALD status was independently associated with DAMA in admitted children (OR=1.30, 95% CI 1.15 to 1.44), outpatients (OR=1.55; 95% CI 1.51 to 1.58) and ED patients (OR=1.60; 95% CI 1.53 to 1.66). Conclusion Being from a CALD background places children at increased risks to DAMA. Implementing appropriate health service responses may ensure equitable access and quality care for children from CALD backgrounds to reduce the rates of DAMA and its associated ramifications.